By Jill Johnston, President, Site Activation, WCG
The site selection and feasibility process shouldn’t be hard. It’s really quite straightforward on paper. And yet, it is astonishingly hard. We all know the dismal numbers; here are just a few to highlight:
- 11% of sites selected never enroll a single patient
- Sponsors’ original timelines end up doubling in order to meet the desired goals (and nearly 80% of clinical trials fail to meet their timelines)
- Operational costs of running a trial are an estimated US $37k/day
What these numbers tell me – and should tell all of us – is that we're simply not doing enough to get the right sites involved in the right trial.
But perhaps we all know that. Here’s the question: Why does the study start-up process fail us so often? That question must be answered if those stats are ever going to change. I believe a maturity model is the way to answer the question.